Impact of PSCA Polymorphisms on the Risk of Duodenal Ulcer
Background: While duodenal ulcer (DU) and gastric cancer (GC) are both H. pylori infection-related diseases, individuals with DU are known to have lower risk for GC. Many epidemiological studies have identified the PSCA rs2294008 T-allele as a risk factor of GC, while others have found an associatio...
Main Authors: | Yoshiaki Usui, Keitaro Matsuo, Isao Oze, Tomotaka Ugai, Yuriko Koyanagi, Yoshinobu Maeda, Hidemi Ito, Asahi Hishida, Kenji Takeuchi, Takashi Tamura, Mineko Tsukamoto, Yuka Kadomatsu, Megumi Hara, Yuichiro Nishida, Ippei Shimoshikiryo, Toshiro Takezaki, Etsuko Ozaki, Daisuke Matsui, Isao Watanabe, Sadao Suzuki, Miki Watanabe, Hiroko Nakagawa-Senda, Haruo Mikami, Yohko Nakamura, Kokichi Arisawa, Hirokazu Uemura, Kiyonori Kuriki, Naoyuki Takashima, Aya Kadota, Hiroaki Ikezaki, Masayuki Murata, Masahiro Nakatochi, Yukihide Momozawa, Michiaki Kubo, Kenji Wakai |
---|---|
Format: | Article |
Language: | English |
Published: |
Japan Epidemiological Association
2021-01-01
|
Series: | Journal of Epidemiology |
Subjects: | |
Online Access: | https://www.jstage.jst.go.jp/article/jea/31/1/31_JE20190184/_pdf |
Similar Items
-
PSCA expression is associated with favorable tumor features and reduced PSA recurrence in operated prostate cancer
by: Marie-Christine Heinrich, et al.
Published: (2018-05-01) -
Impact of DCC (rs714) and PSCA (rs2294008 and rs2976392) Gene Polymorphism in Modulating Cancer Risk in Asian Population
by: Vishal Chandra, et al.
Published: (2016-02-01) -
Prostate stem cell antigen (PSCA) expression in human prostate cancer tissues and its potential role in prostate carcinogenesis and progression of prostate cancer
by: Wenlv Shen, et al.
Published: (2004-05-01) -
Construction of a fusion plasmid containing the PSCA gene and cytotoxic T-lymphocyte associated antigen-4 (CTLA-4) and its anti-tumor effect in an animal model of prostate cancer
by: T.J. Mai, et al. -
Co-stimulatory signaling determines tumor antigen sensitivity and persistence of CAR T cells targeting PSCA+ metastatic prostate cancer
by: Saul J. Priceman, et al.
Published: (2018-02-01)